{"name":"Zenyaku Kogyo Co., Ltd.","slug":"zenyaku-kogyo-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQekhYVnpMM0U5ZDIxd1FnU1N1NmxyLVVkbFktWG5uOGxueVQ5c3FnR0ZfV0JVNERIdUg1SkNEWWk5bkR1djhIQmkxN2Z4djVjNHQxbm1jV0pIaFgxd2tYNW1FTU4wVFdlWDFTS0ZmRWFlTXNvTGVpRmc0MU5Oak16NUxUcmwwQ202T29aVDlFODd4b2VZeU5VZW41cnpIMkZK?oc=5","date":"2026-04-07","type":"pipeline","source":"openPR.com","summary":"Leading Companies Reinforcing Their Presence in the Farm Animal Drugs Market - openPR.com","headline":"Leading Companies Reinforcing Their Presence in the Farm Animal Drugs Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPanNWdUZyeUtQY2MwOGRPQTlDUzZUNzQwYVJ1LWJ5N2puZExHNWRZVDFPRzNyWEtZU0tyVGk0c2RUNzhRbW9FM1Nicmxqci13cnR3R2tHWkp3a3YyZHVvSXQ5YmttYl9Ha2RrVkQxWmViX1hiQm5XbkR5a3YtMzE4MHBoRzlTNU1mTVlGVGhDeHpoY2JYZ0FB?oc=5","date":"2026-04-07","type":"trial","source":"openPR.com","summary":"In-Depth Study of Segments, Industry Developments, and Key Players in the Pet Cancer Therapeutics Market - openPR.com","headline":"In-Depth Study of Segments, Industry Developments, and Key Players in the Pet Cancer Therapeutics Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1PM1UtN2hfVmdDNThjSGtJV3QwQ1NQWVhQSkhLWENYbDkyai1NNy1GenROSzhrRHRxVFFsYkNvMGwzU05xWmdZTHhUMFFLdnNOOVRoWThuV2wtN2NPMnJn?oc=5","date":"2025-10-10","type":"trial","source":"Nature","summary":"Rituximab-induced long-term remission in childhood-onset, uncomplicated, frequently relapsing or steroid-dependent nephrotic syndrome: a randomized, placebo-controlled trial and a follow-up study - Na","headline":"Rituximab-induced long-term remission in childhood-onset, uncomplicated, frequently relapsing or steroid-dependent nephr","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQMW91WkQyMFdkSDJUQ3hybFM3Z01xQmRDZ2JNbnlIV1NrVUlLM1Vvd0VDUVlsN21halhvRGI4S19XN2FsOFk2QmJCWW5yVi1qTGx0UEw3SWZuSFB5TXV1bU1iamhRRU15TE8tTl9jREdJQ2ttb2ZLOHRRcDN0TDFJVUdvQXhZcHpsVG95Sm5zZWJFVmtaVDJTcFNfcVQ?oc=5","date":"2025-06-30","type":"pipeline","source":"Frontiers","summary":"Case Report: Dural infiltration of intervertebral disc material mimicking spinal cord meningioma in a dog - Frontiers","headline":"Case Report: Dural infiltration of intervertebral disc material mimicking spinal cord meningioma in a dog","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPU1VsbkdJd1FFTFpTbDBOUjN6NWE5dUVhNC03TUpDZ3c5aTU1eTBaUXNVUkJQTGFwZ0NFeHF3WVVIUTBfbTNwNm91TFFvcU5QWkZlMk00NmpraHZwMmNKb2JqTWFFWF9ibll4Q3FtemRhR1c0NERPWGdORzBDcWM3NDBFX0lSZkVO?oc=5","date":"2025-06-16","type":"patent","source":"Insightace Analytic","summary":"Rituximab Biosimilar Market Share, Size, Growth and Forecast to 2034 - Insightace Analytic","headline":"Rituximab Biosimilar Market Share, Size, Growth and Forecast to 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNN0ZvYmlZbjFKQVB2cFM3Zmc1RHFONk54ZHhoazRLUE5hRzJJeXBieHdZVXE4aFdNc3JWc25sallVNi1BX1pjUG05VjFzSUdCTUR2dVdURWJGTFV6b2ZMa2IwRVNJcnRUY2ZnZlVoOFFZSS1BdHF0ajg4U2lFZ0pXMzJFb1NyX0pPTkxzU0RSQ3k5NXh1Sm5vN2sxVWZ4UDhmeVczNHkzQU1TU0doWW1nbGk0OGRvUThzWUl3T3JlMjMzZ00zT0Q0bTBPOGFlTUdJMzVwMXFUTlZSbXRrbl93?oc=5","date":"2025-03-19","type":"pipeline","source":"PR Newswire","summary":"CABLIVI Market Reports Positive Growth - Strong Momentum Expected to Continue | DelveInsight - PR Newswire","headline":"CABLIVI Market Reports Positive Growth - Strong Momentum Expected to Continue | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBHaUwteHZ4STgxaEpMWWRKT3I2ZE1sSFRMZWJYdm1aUG1TS3VVbFBxWUZKV05xRHBxRzc0U25WLURIVVZyZFdfaHUzYlV6Ym5KMDdaWUh4NXpRQlUzOWFB?oc=5","date":"2025-02-17","type":"trial","source":"Nature","summary":"Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study | Leukemia - Nature","headline":"Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study | Leukemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNUHR5T203dTZKYzVDazNILXF4MFNQbFJibE9Oc3RQaFFpTlFfN0tiWVM4djNKNGRyTkE3QWE2aVRJdW11bnV0ZG4wTXF5S29zcHhKZmNVdm9wY1BsMHZqbGw4T3JFaVJJNm5rRUZlckczbU92aG9WQkp2QUltcWtSWjYxOWpsVVp5MmpfMUtGQkdMVVhnSzJwaWY2NEdobU55cC1VMW02TlRwNUNMa3psaTNJWGhNenhKT3JvMmJLa3M?oc=5","date":"2024-09-04","type":"pipeline","source":"PR Newswire","summary":"Global Heparin Market to Reach ~USD 15 Billion by 2030 | DelveInsight - PR Newswire","headline":"Global Heparin Market to Reach ~USD 15 Billion by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQS29ONVJaOEt1dXd4U1NuS0tEcTA0UGZBSFdVV25EQTNjT2tqOHprb2ZQa0pZdS05SGV5TkNuQ29zcVdMTmQ3ZFNGMUx3U3R3bUVQX3BKSV8zWUdvSURDMXNUeWY3dGI3em5fVU1XWDEweWU5WUsyR0lvNVV6N3JFYzU1WXhfMlUxMXVnRDB3cWhsSlAzQUI4NC1sSmptNGczOGYyTUJ6dnBiT1kzMzVaSHBkNGNGbDVLT0k4d2swdkw1X3JEVmRkcDVvOFBNUFROaDV3?oc=5","date":"2023-07-11","type":"trial","source":"BioWorld News","summary":"Aslan shares slide on mixed phase IIb data for eblasakimab, chasing Dupixent in atopic dermatitis - BioWorld News","headline":"Aslan shares slide on mixed phase IIb data for eblasakimab, chasing Dupixent in atopic dermatitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxOUTI0bEpaeFdsY1VkSVVlZ2hqa3Jhc2ZsaXFRZUc4enFsNVlVVlpTN0FmOGFBRF9pRTZ2NnE5UzF2QzBtOXVUS3VwVF9NRE9DanVBd3B3MlE2R1JzZGhGajBEemhHTDFoRkVtMWYzdGVxTXdXT2Vyd3lCak1NTEN5UVhsZ1NZRW1yam0zbGdNQ0R3SEo1NFZsMDFMUmNtQjN2THFLRjFGQWEwaHE3SkF2OEU1Wll4REtCS21teFliUFV1Q3FUUnptTG9RNG1VVjdjWWNTU3VIbk5UYXAxNlNHc0lVY3RKVVBVM1RjSjREbzhOSTNnSE43WGpibmVwNzBYQnc1RU1DYTJPcko4ZlJ0bHZtbGNZemNwWW1ySnd5OUM3RUFYSUFOSVUzeWRScVVQMXRSVDI0S19tU3FCVGc?oc=5","date":"2023-06-22","type":"pipeline","source":"GlobeNewswire","summary":"ASLAN Pharmaceuticals Enters Into a Strategic Licensing - GlobeNewswire","headline":"ASLAN Pharmaceuticals Enters Into a Strategic Licensing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5sbUp0OUgwaExxVXBuZHNfdUx5dllqYUxVV0paRjNRZVRZakNhODE4OFA4dmJOMGY4TWhTZGZ0Y0VvOHN3SW9RTDFKZW1qYTd0S1RV?oc=5","date":"2023-02-16","type":"pipeline","source":"Market.us","summary":"Oncology Market Size, Share, Growth | CAGR of 12% - Market.us","headline":"Oncology Market Size, Share, Growth | CAGR of 12%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQNmVIckNtNnNfenZZRWtRMzhQakdyS2pnT1QxamJ5ejI2d2dZMXdjcUFjcmZtYnRKMk9ESW5TQnlyM0V4V0tGMnplY01FR05HNXExNVpQOFVJWUh1ZWFwNDVUUFAxb0VDYmhJMFcwU2lxb0pkaDBKNUpaa3dpYllKWkdn?oc=5","date":"2023-02-09","type":"pipeline","source":"Spherical Insights","summary":"Japan Veterinary Healthcare Market Growth, Share, Report to 2030 - Spherical Insights","headline":"Japan Veterinary Healthcare Market Growth, Share, Report to 2030","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}